Anterior Skull Base Tumors. Группа авторов
Чтение книги онлайн.
Читать онлайн книгу Anterior Skull Base Tumors - Группа авторов страница 27
![Anterior Skull Base Tumors - Группа авторов Anterior Skull Base Tumors - Группа авторов Advances in Oto-Rhino-Laryngology](/cover_pre941662.jpg)
5Skull base reconstruction failure. From the data available in the literature it emerges that the most common major complication of skull base reconstruction is cerebrospinal fluid leak (CSF-L) in the postoperative period, with a prevalence of 3–4.3% [22–24]. A recent report published by an Italian center has shown a CSF-L rate after anterior skull base reconstruction of about 5.8% [27]. Another series from an Italian center analyzed 62 patients who underwent endoscopic tumor removal: the authors found that the risk of CSF-L is related to the learning curve of the surgeon and refinement of the surgical technique [16]. Even other reports published in the literature, such as that from the University of Pittsburgh Medical Center, have shown that the surgical experience plays a strategic role in the success of anterior skull base reconstruction after tumor removal with a CSF-L rate as high as 20–30% in the case of early reconstructive experience [24, 25]. As a last remark, the risk of brain herniation, a rare and life-threatening complication, may occur more easily in cases of intracranial hypertension (high BMI, OSAS), and in concomitant neck dissection with the injury or postoperative thrombosis of a dominant internal jugular vein [20].
Conclusions
EER, when properly planned and performed by experienced surgeons, is the ideal treatment for a large number of skull base malignancies, in association with appropriate adjuvant/neoadjuvant therapies, with long-term outcomes comparable to those achieved with traditional external approaches [21]. EER should be performed only in high-specialized centers and by surgeons with extensive endoscopic experience. Long and dedicated training in the treatment of inflammatory and benign endonasal lesions is required, with accurate and precise knowledge of sinonasal and skull base anatomy.
Lastly, multidisciplinary team-work is of utmost importance, with the cooperation of several specialists, including otolaryngologists, neurosurgeons, ophthalmologists, radiation oncologists, medical oncologists, occupational physicians, and pathologists [2–5]. To date, due to the rarity of sinonasal and skull base tumors, further studies with longer pathology-specific follow-up are needed to validate and confirm these statements and to refine the role of endoscopic endonasal surgery in the setting of multidisciplinary care.
Disclosure Statement
All authors have no conflict of interest to declare.
References
1Lund VJ, Stammberger H, Nicolai P, Castelnuovo P, Beal T, Beham A, Bernal-Sprekelsen M, Braun H, Cappabianca P, et al: European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinology Suppl 2010;22:1–143.
2Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY: Endoscopic resection of sinonasal cancers. Curr Oncol Rep 2014;16:369.
3Hagemann J, Roesner J, Helling S, Jacobi C, Doescher J, Engelbarts M, Kuenzel J, Krauss P, Becker S, Betz CS: Long-term outcome for open and endoscopically resected sinonasal tumors. Otolaryngol Head Neck Surg 2019;160:862–869.
4Castelnuovo P, Battaglia P, Turri-Zanoni M, Tomei G, Locatelli D, Bignami M, Villaret AB, Nicolai P: Endoscopic endonasal surgery for malignancies of the anterior cranial base. World Neurosurg 2014;82:22–31.
5Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D: Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin North Am 2016;49:183–200.
6Mattavelli D, Ferrari M, Bolzoni Villaret A, Schreiber A, Rampinelli V, Turri-Zanoni M, Lancini D, Taglietti V, Accorona R, Doglietto F, Battaglia P, Castelnuovo P, Nicolai P: Transnasal endoscopic surgery in selected nasal-ethmoidal cancer with suspected brain invasion: indications, technique, and outcomes. Head Neck 2019;41:1854–1862.
7Castelnuovo PG, Belli E, Bignami M, Battaglia P, Sberze F, Tomei G: Endoscopic nasal and anterior craniotomy resection for malignant nasoethmoid tumors involving the anterior skull base. Skull Base 2006;16:15–18.
8Ketcham AS, Wilkins RH, Vanburen JM, Smith RR: A combined intracranial facial approach to the paranasal sinuses. Am J Surg 1963;106:698–703.
9Patel SG, Singh B, Polluri A, Bridger PG, Cantu G, Cheesman AD, deSa GM, Donald P, Fliss D, Gullane P, Janecka I, Kamata SE, Kowalski LP, Kraus DH, Levine PA, dos Santos LR, Pradhan S, Schramm V, Snyderman C, Wei WI, Shah JP: Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer 2003;98:1179–1187.
10Castelnuovo P, Battaglia P, Locatelli D: Endonasal micro-endoscopic treatment of the malignant tumors of paranasal sinuses and anterior skull base. Op Tech Otolaryngol 2006;17:152–167.
11Tajudeen BA, Adappa ND, Kuan EC, Schwartz JS, Suh JD, Wang MB, Palmer JN: Smell preservation following endoscopic unilateral resection of esthesioneuroblastoma: a multi-institutional experience. Int Forum Allergy Rhinol 2016;6:1047–1050.
12Schreiber A, Ferrari M, Mattavelli D, Rampinelli V, Taboni S, Vural A, Bignami M, Castelnuovo P, Nicolai P: Unilateral endoscopic resection with transnasal craniectomy for sinonasal intestinal-type adenocarcinoma: a bi-institutional case-control study on 54 patients. Oral Oncol 2018;87:89–96.
13Turri-Zanoni M, Battaglia P, Karligkiotis A, Lepera D, Zocchi J, Dallan I, Bignami M, Castelnuovo P: Transnasal endoscopic partial maxillectomy: operative nuances and proposal for a comprehensive classification system based on 1,378 cases. Head Neck 2017;39:754–766.